Pfizer, WellPoint Count on Senate to Soften House Health Bill (Bloomberg)
November 9, 2009
Nov. 9 (Bloomberg) -- Drugmakers including Pfizer Inc. and health insurers such as WellPoint Inc. are looking to the U.S. Senate to revamp House-passed legislation overhauling the health-care system that threatens to squeeze profits.
Return to Epilepsy News
